Merit Medical Systems MMSI Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $41M+7.9% | $38.01M+36.9% | $27.76M-14.8% | $32.58M+8.1% | $30.15M+7.9% | ||
| $30.5M-3.3% | $31.54M+0.7% | $31.32M+1.0% | $31.02M+5.9% | $29.29M+2.4% | ||
| $8.96M-9.5% | $9.9M-27.3% | $13.61M+25.2% | $10.87M+19.8% | $9.08M-4.6% | ||
| $1.41M— | —— | —— | —— | $1.41M— | ||
| $137K-14.9% | $161K+130% | $70K+40.0% | $50K+56.3% | $32K-41.8% | ||
| -$67K+96.2% | -$1.76M-660% | -$231K-1.3% | -$228K-162% | -$87K+93.2% | ||
| $3.58M— | —— | $6.35M— | —— | $7.56M+82.3% | ||
| $22.66M+247% | $6.53M+94.7% | $3.35M+199% | $1.12M-89.4% | $10.6M— | ||
| $4.49M— | —— | —— | —— | $4.45M— | ||
| -$33.27M-453% | $9.41M+24.0% | $7.59M-57.9% | $18.01M+187% | -$20.75M-301% | ||
| -$1.89M— | —— | $463K-90.0% | $4.62M+326% | -$2.04M— | ||
| $15M+8,526% | -$178K— | —— | -$1.5M-104% | -$733K— | ||
| -$314K-101% | $60.5M+28.1% | $47.23M-6.9% | $50.73M+387% | $10.43M-74.4% | ||
| $7.46M+327% | $1.75M-10.4% | $1.95M— | $0-100% | $1.92M— | ||
| -$531K— | —— | —— | —— | —— | ||
| $2.85M+2.4% | $2.79M-4.7% | $2.93M+5.2% | $2.78M-6.8% | $2.98M+0.1% | ||
| -$2.77M-6.8% | -$2.59M+2.4% | -$2.65M-2.4% | -$2.59M+22.3% | -$3.34M-6.7% | ||
| -$179K— | —— | $32K-77.6% | $143K-86.0% | $1.02M+577% | ||
| -$2.07M+8.2% | -$2.25M— | —— | -$3.1M-1,192% | $284K-84.3% | ||
| $40.68M-58.7% | $98.51M+31.4% | $74.98M-10.0% | $83.31M+105% | $40.57M-41.0% | ||
| $16.01M-34.6% | $24.46M+9.0% | $22.44M+63.2% | $13.75M-34.7% | $21.06M+507% | ||
| $1M-95.4% | $21.94M+7,762% | $279K-99.8% | $121.56M+12,056% | $1M-99.5% | ||
| $25.5M— | —— | —— | —— | —— | ||
| $757K-4.5% | $793K-23.1% | $1.03M+22.9% | $839K+83.6% | $457K-40.3% | ||
| $7.73M+115% | -$50.34M-109% | -$24.07M+83.2% | -$143.35M-384% | -$29.64M+86.2% | ||
| —— | —— | —— | —— | —— | ||
| $2.78M-54.0% | $6.03M+179% | $2.17M-68.4% | $6.86M-47.8% | $13.15M-48.4% | ||
| $2.14M+5,255% | $40K-48.7% | $78K-96.9% | $2.52M+4,737% | $52K0.0% | ||
| -$6.29M-224% | $5.06M— | $0-100% | $4.35M-37.5% | $6.96M— | ||
| -$426K-157% | $751K+699% | $94K-95.3% | $2.02M+115% | $936K+129% | ||
| $41.7M-22.8% | $53.99M+6.6% | $50.65M+194% | -$53.68M-385% | $18.83M+113% | ||
| $10.72M— | —— | $12.36M+957% | $1.17M-90.5% | $12.36M+445% | ||
| $4.38M-45.7% | $8.07M+120% | $3.67M-76.9% | $15.87M+320% | $3.78M-68.4% | ||
| $1.41M— | —— | —— | —— | $1.41M— | ||
| -$179K— | —— | $32K-77.6% | $143K-86.0% | $1.02M+577% | ||
| -$67K+96.2% | -$1.76M-660% | -$231K-1.3% | -$228K-162% | -$87K+93.2% | ||
| $12.5M+19,984% | $62.25K0.0% | $62.25K0.0% | $62.25K0.0% | $62.25K— | ||
| -$531K— | —— | —— | —— | —— | ||
| $4.49M— | —— | —— | —— | $4.45M— | ||
| -$169K— | —— | -$2.72M-330% | $1.18M+304% | -$580K— | ||
| -$188K+51.3% | -$386K+89.0% | -$3.51M-161% | $5.8M+370% | -$2.14M— | ||
| -$2.77M-6.8% | -$2.59M+2.4% | -$2.65M-2.4% | -$2.59M+22.3% | -$3.34M-6.7% | ||
| $723K— | $0-100% | $358K-72.4% | $1.3M+636% | $176K-92.0% | ||
| -$2.07M+8.2% | -$2.25M— | —— | -$3.1M-1,192% | $284K-84.3% | ||
| -$1.89M— | —— | $463K-90.0% | $4.62M+326% | -$2.04M— | ||
| $2.85M+2.4% | $2.79M-4.7% | $2.93M+5.2% | $2.78M-6.8% | $2.98M+0.1% | ||
| $757K-4.5% | $793K-23.1% | $1.03M+22.9% | $839K+83.6% | $457K-40.3% | ||
| —— | $75.75K0.0% | $75.75K0.0% | $75.75K0.0% | $75.75K+5,960% | ||
| —— | —— | —— | —— | —— | ||
| $6.92M+643% | $932K-62.0% | $2.45M— | $0-100% | $6.15M— | ||
| -$426K-157% | $751K+699% | $94K-95.3% | $2.02M+115% | $936K+129% | ||
| $1.78M-7.4% | $1.93M-14.5% | $2.25M-38.0% | $3.63M-85.4% | $24.87M+3,190% | ||
| $4.38M-45.7% | $8.07M+120% | $3.67M-76.9% | $15.87M+320% | $3.78M-68.4% | ||
| $24.67M-66.7% | $74.05M+40.9% | $52.54M-24.5% | $69.56M+256% | $19.51M-70.1% | ||
| $24.67M-66.7% | $74.05M+40.9% | $52.54M-24.5% | $69.56M+256% | $19.51M-70.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Merit Medical Systems's cash flow data come from?
- Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.